Plasma concentrations of buprenorphine 24 to 72 hours after dosing
- 28 July 1999
- journal article
- clinical trial
- Published by Elsevier
- Vol. 55 (1-2) , 157-163
- https://doi.org/10.1016/s0376-8716(98)00192-6
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Relationship of plasma buprenorphine and norbuprenorphine to withdrawal symptoms during dose induction, maintenance and withdrawal from sublingual buprenorphineAddiction, 1998
- A Controlled Trial Comparing Buprenorphine and Methadone Maintenance in Opioid DependenceArchives of General Psychiatry, 1996
- Buprenorphine Versus Methadone in the Treatment of Opioid DependenceJournal of Clinical Psychopharmacology, 1996
- A Pilot Study of Primary-Care—Based Buprenorphine Maintenance for Heroin DependenceThe American Journal of Drug and Alcohol Abuse, 1996
- Buprenorphine treatment of opioid dependence: clinical trial of daily versus alternate-day dosingDrug and Alcohol Dependence, 1995
- Alternate-day dosing during buprenorphine treatment of opioid dependenceLife Sciences, 1994
- Buprenorphine versus methadone in the treatment of opioid-dependent cocaine usersPsychopharmacology, 1994
- Buprenorphine versus Methadone Maintenance for Opioid DependenceJournal of Nervous & Mental Disease, 1993
- The fifth edition of the addiction severity indexJournal of Substance Abuse Treatment, 1992
- The use of the Center for Epidemiologic Studies Depression Scale in adolescents and young adultsJournal of Youth and Adolescence, 1991